Boston Partners’s Antares Pharma, Inc. ATRS Stock Holding History

Boston Partners’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-420,620	Closed	-$1.73M	–	749
2022 Q1	$1.73M	Buy	420,620 +243,758	+138%	+$884K	﹤0.01%	483
2021 Q4	$631K	Buy	176,862 +59,488	+51%	+$208K	﹤0.01%	588
2021 Q3	$427K	Buy	+117,374	New	+$475K	﹤0.01%	619

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boston Partners's ATRS Position: Q2 2022 in Review

Boston Partners sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 420,620 shares — an estimated $1.73M sold.

Boston Partners first reported a position in ATRS in Q3 2021 and held it in 3 quarters. The position peaked at $1.73M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Boston Partners reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Boston Partners sold 420,620 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.73M.
Boston Partners first reported a position in Antares Pharma, Inc. in Q3 2021 and held it in 3 quarters.
Boston Partners's Antares Pharma, Inc. position peaked at $1.73M in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Boston Partners's 13F filing for Q2 2022, filed 10 Aug 2022.